Malignant peritoneal mesothelioma

Stopping Mesothelioma, US May Ban Asbestos

2010-08-01T19:23:00.000-07:00

Aug 2, 2010 - In 1989, the Environmental Protection Agency tried to ban the use of products containing asbestos, as it has been known to cause mesothelioma. Malignant mesothelioma is a relatively rare type of cancer, and may be caused by exposure to the substance known as asbestos.

In spite of the ban issued on products containing asbestos by the EPA during that time, the rule was soon overturned by the Fifth Circuit Court of Appeals in New Orleans. In recent years, the attempts to reinstate laws that ban the use of the cancer-causing substance have not worked out all that well, though it seems that the EPA is taking action to ensure the use of asbestos is prohibited within the next ten years.

The ban on the use of asbestos will come about in two stages. First, it will be ensured that asbestos may not be used as a sealing agent as part of construction work, and secondly it will be banned from use in tiles, linings, and cement panels.

According to statistics by the World Health Organization, diseases such as mesothelioma which are caused by asbestos result in about 90,000 deaths each year. Recently in Spain, a company was ordered by the court to pay nearly $5 million in asbestos-related damages, causing nearby residents to incur a variety of health issues such as mesothelioma.

source: clicknews.org

Measurement of Mesothelioma Tumor Volume Aids in Prognosis

2010-08-01T19:19:00.000-07:00

In a recent study from Columbia University, researchers found measuring mesothelioma tumors may provide additional insight into effective treatment options and other prognostic factors.

Mesothelioma is a form of cancer most notably caused by asbestos exposure. Symptoms of this rare condition can take decades to arise and many patients are diagnosed during the latest stage of development as a result. With such a late diagnosis, the mesothelioma life expectancy for most patients ranges between four and 18 months.

The purpose of the study was to calculate the tumor volume in pleural mesothelioma patients by using computer tomography scan images and a computerized measurement technique. They wanted to evaluate the changes in volume after chemotherapy and whether the change could help predict overall survival in patients.

Between two clinical trials, 30 patients were studied after being treated with a combination of chemotherapy, surgery and radiation therapy. Tumor volumes were evaluated after two cycles of chemotherapy and changes were measured by percentages.

The percentage change of tumor volume between the initial measurement and the evaluation after two chemotherapy cycles was greatly associated with overall survival. Patients were divided into an “increase” or “decrease” group.

F. Liu and colleagues at Columbia University concluded that “Computer-aided volumetric measurements may enable more reliable therapeutic response assessment and could provide additional prognostic information.”

The study, titled “Assessment of Therapy Responses and Prediction of Survival in Malignant Pleural Mesothelioma Through Computer-Aided Volumetric Measurement on Computed Tomography Scans,” can be found in the Journal of Thoracic Oncology.

Additional information on mesothelioma may be found through the Mesothelioma Center.

source: www.asbestos.com

Pleural Mesothelioma One of Few Thoracic Cancers to Spontaneously Regress

2010-08-01T19:05:00.000-07:00

In a study recently published in the medical journal Respiratory Medicine, researchers investigated the history of spontaneous regression of thoracic malignancies to determine the incidence and the types of thoracic cancers most likely to spontaneously regress.

Malignant mesothelioma is a rare cancer caused by asbestos exposure. The majority of cases affect the pleural lining of the lungs, which classifies this form of mesothelioma as a thoracic malignancy. It typically takes 20 to 50 years for the cancer to develop after repeated exposure to asbestos and there currently is no cure for mesothelioma. Some patients have experienced an improvement in their mesothelioma life expectancy by undergoing multimodality therapy, which combines several forms of treatment to combat the cancer.

The research for this study involved a PubMed search of the phrase “spontaneous regression of thoracic lesions” published between 1951 through December 2008. A total of 76 cases involved spontaneous regression of metastatic thoracic tumors, of which five cases reported regression of the primary thoracic tumors along with pulmonary metastasis.

Thus, researchers found only five cases that reported spontaneous regression of a primary thoracic cancer. Of the five cases, two were pleural mesothelioma, two were primary lung cancer (squamous cell) and one was adenoid cystic carcinoma.

Of the 76 cases found to include spontaneous regression of thoracic tumors, renal cell carcinoma was the most common, accounting for 60 percent of cases. Spontaneous regression of thoracic tumors was more common in men than women. Researchers observed that the rare spontaneous regression of a primary thoracic malignancy seems to follow surgical resection of the primary tumor.

Researchers concluded, “Spontaneous regression of thoracic malignancies is rare. Regression of primary thoracic malignancies has been reported only with squamous and bronchogenic carcinoma, pleural mesothelioma and adenoid cystic carcinoma. Regression of thoracic metastases, on the other hand, has been reported in many more malignancies but the overwhelming majority of cases involve metastatic renal cell carcinoma. Overall, this still appears to be a rare event, but when it occurs, it seems to follow resection of the primary tumor.”

Additional information on mesothelioma may be found through the Mesothelioma Center.

Malignant Pleural Mesothelioma

2007-12-27T08:15:00.000-08:00

Malignant pleural mesothelioma is a cancer of the thin layer of tissue that lines the chest and lungs. It is a rare form of cancer that is mostly associated with exposure to asbestos. Malignant pleural mesothelioma is a fast-moving cancer with a median survival time of between one and two years.

The majority of mesotheliomas are associated with asbestos exposure. Asbestos was used widely in the United States for insulation, and while awareness of its harmful effects is increasing, asbestos can still be found in older buildings. People who work in industries using asbestos in some form, such as insulation manufacturers, insulation workers, and ship builders, may be at increased risk to develop mesotheliomas. The time between exposure and development of a cancer may be decades, which is why it is usually diagnosed in older people. More men than women get this type of cancer. Close contacts of people who have been exposed to asbestos, such as family members, may also be at risk.

Some symptoms of this cancer are increasing breathlessness, pain in the chest or under the ribcage, an abdominal lump or swelling, fever and unexplained weight loss. Imaging tests like a CT scan may show a collection of fluid in the pleural cavity of the chest. Pleural tissue and fluid is also tested to detect cancerous cells and certain chemicals that can rule out a diagnosis of pleural mesothelioma.

Depending on the extent of spread of cancer, malignant pleural mesotheliomas are conventionally treated with some combination of chemotherapy, radiotherapy and surgery to remove as much of the cancer as possible. Aggressive treatment strategies are the norm, though the exact treatment depends on how far the cancer has spread. A number of experimental treatments are currently being evaluated in clinical trials.

Malignant Mesothelioma provides detailed information about malignant mesothelioma, diffuse malignant pleural mesothelioma, malignant mesothelioma diagnosis, malignantPeritoneal Mesothelioma Lawyers. mesothelioma lawyer and more. Malignant Mesothelioma is the sister site of

Article Source: http://EzineArticles.com/?expert=Elizabeth_Morgan

Malignant Hypertension Symptoms Treatment

2007-12-02T08:19:00.000-08:00

By Armughan Riaz

Malignant Hypertension and accelerated high blood pressure are two emergency conditions which should be treated promptly. Both conditions have same outcome and therapy. However Malignant hypertension is a complication of high blood pressure characterized by very elevated high blood pressure, and organ damage in the eyes, brain, lung and/or kidneys. It differs from other complications of hypertension in that it is accompanied by papilledema. (Edema of optic disc of eye) Systolic and diastolic blood pressures are usually greater than 240 and 120, respectively. While Accelerated high blood pressure is condition with high blood pressure, target organ damage, on fundoscopy we have flame shaped hemorrhages, or soft exudates, but without papilledema.

There are two things. Hypertensive Urgency and Hypertensive emergency. In hypertensive urgency we don’t see any target organ damage while in emergency we see target organ damage along with high blood pressure greater than systolic >220. Now depending upon target organ damage you will decide whether you have hypertensive emergency or urgency. It is essential to bring down high blood pressure in hypertensive emergency immediately, while in urgency, bring down blood pressure very rapidly is not required.

Pathogenesis of malignant hypertension is fibrinoid necrosis of arterioles and small arteries. Red blood cells are damaged as they flow through vessels obstructed by fibrin deposition, resulting in microangiopathic hemolytic anemia. Another pathologic process is the dilatation of cerebral arteries resulting in increased blood flow to brain which leads to clinical manifestations of hypertensive encephalopathy. Common age is above 40 years and it is more frequent in man rather than women. Black people are at higher risk of developing hypertensive emergencies than the general population.

Target organs are mainly Kidney, CNS and Heart. So symptoms of Malignant hypertension are oligurea, Headache, vomiting, nausea, chest pain, breathlessness, paralysis, blurred vision. Most commonly heart and CNS are involved in malignant hypertension. The pathogenesis is not fully understood. Up to 1% of patients with essential hypertension develop malignant hypertension, and the reason some patients develop malignant hypertension while others do not is unknown. Other causes include any form of secondary hypertension; use of cocaine, MAOIs, or oral contraceptives; , beta-blockers, or alpha-stimulants. Renal artery stenosis, withdrawal of alcohol, pheochromocytoma {most pheochromocytomas can be localized using CT scan of the adrenals}, aortic coarctation, complications of pregnancy and hyperaldosteronism are secondary causes of hypertension. Main Investigations to access target organ damage are complete renal profile, BSR, Chest Xray, ECG, Echocardiography, CBC, Thyroid function tests.

Management:

Patient is admitted in Intensive Care Unit. An intravenous line is taken for fluids and medications. The initial goal of therapy is to reduce the mean arterial pressure by approximately 25% over the first 24-48 hours. However Hypertensive urgencies do not mandate admission to a hospital. The goal of therapy is to reduce blood pressure within 24 hours, which can be achieved as an outpatient department. Initially, patients treated for malignant hypertension are instructed to fast until stable. Once stable, all patients with malignant hypertension should take low salt diet, and should focus on weight lowering diet. Activity is limited to bed rest until the patient is stable. Patients should be able to resume normal activity as outpatients once their blood pressure has been controlled.

Hospitalization is essential until the severe high blood pressure is under control. Medications delivered through an IV line, such as nitroglycerin, nitroprusside, or others, may reduce your blood pressure. An alternative for patients with renal insufficiency is IV fenoldopam. Beta-blockade can be accomplished intravenously with esmolol or metoprolol. Labetalol is another common alternative, providing easy transition from IV to oral (PO) dosing. Also available parenterally are enalapril, diltiazem, verapamil, Hydralazine is reserved for use in pregnant patients as it also increases uterine profusion, while phentolamine is the drug of choice for a pheochromocytoma crisis. After the severe high blood pressure is brought under control, regular anti-hypertensive medications taken by mouth can control your blood pressure. The medication may need to be adjusted occasionally.

Remember, It is very necessary to control malignant hypertension, otherwise it can lead to life threatening conditions like Heart Failure, Infarction, Kidney failure and even blindness.

Dr Armughan, Author of this article. Read More about Malignant Hypertension

Article Source: http://EzineArticles.com/?expert=Armughan_Riaz

Peritoneal Mesothelioma Treatment

2007-10-02T06:55:00.000-07:00

By Marcus Peterson

Peritoneal mesothelioma treatment depends upon a number of factors, such as the size and stage of cancer cells, the patient’s general condition and health, past medical history of the patient and the patient’s age. Peritoneal mesothelioma is the cancer of the membrane in the abdomen. As with all cancer diseases, premature detection and treatment provides the best possible result.

Peritoneal mesothelioma treatments are classified into localized treatments and systemic treatments. Systemic treatments are whole body treatments like chemotherapy. Localized treatments include surgery and radiotherapy.

Surgical treatment is often not practical in the case of peritoneal mesothelioma. If the growth of cancer cell is found very early, it may be possible to remove tumor by operation. The peritoneal mesothelioma surgery is known as a peritonectomy. The surgery involves cutting out the peritoneum, the lining of the abdomen where the mesothelioma has started growing. Sometimes it is needed to remove a lung or part of the diaphragm, for the surgery to succeed in removing the afflicted cell.

Radiation therapy or radiotherapy uses high energy rays (like x-rays) to kill cancer cells in the affected area. There are several ways to administer radiotherapy and each one breaks down the cancer cells so that they may be eliminated from the body. The general method includes a machine kept outside the body, which produces radiation. Another method is by placing a radiation-emitting device directly to the affected cell by way of plastic tubes. In addition to controlling radiation, doctors use these tubes to inject the required drugs.

Chemotherapy for peritoneal mesothelioma controls symptoms and tries to slow the cancer down. This therapy is used to kill mesothelioma cells by injecting anti-cancer drugs that are usually injected into a vein. Medicines can be administered in tablet form. Depending on the type of medicine used, the treatment can be applied weekly or every two to three weeks.

Peritoneal mesothelioma does not always respond to traditional mesothelioma treatment ways. Physicians and researchers are constantly working to improve upon the existing peritoneal mesothelioma treatment.

Mesothelioma Treatment provides detailed information on Mesothelioma Treatment, Mesothelioma Treatment Options, Alternative Mesothelioma Treatment, New Mesothelioma Treatment and more. Mesothelioma Treatment is affiliated with Mesothelioma Doctors Info.

Article Source: http://EzineArticles.com/?expert=Marcus_Peterson

2007-09-18T05:31:00.000-07:00

Malignant peritoneal mesothelioma. (a) Axial contrast-enhanced CT scan shows a heterogeneously enhancing mass in the left upper quadrant (arrows).

Such a marked response to chemotherapy is rare in an advanced malignant peritoneal mesothelioma such as the present case. Eight months later, the tumor

The varied morphology of peritoneal malignant mesotheliomas may raise a broad differential diagnosis, but in most cases the resemblance to other tumors is .

Median survival of diffuse malignant peritoneal mesothelioma using traditional treatment modalities (combined pleural and peritoneal mesothelioma*).

Malignant mesothelioma is relatively rare. disease, that is found in only 0.01-0.1% of all. autopsied cases (5). Malignant peritoneal

There are two common types of malignant mesothelioma: Pleural mesothelioma and Peritoneal mesothelioma. Pleural mesothelioma is cancer of the pleura,

7 Feb 2006 ... Malignant Peritoneal Mesothelioma is neoplasm arising from the serosal lining of the peritoneal and pericardial cavities.

Malignant Peritoneal Mesothelioma in Women. 90. Ovarian Cancer.

With peritoneal malignant mesothelioma, malignant ascites is a common presentation and a major factor in disease-related morbidity and mortality.

Malignant peritoneal mesothelioma is a rare but aggressive tumor derived from ... Association of malignant peritoneal mesothelioma and asbestos exposure has

Unfortunately, due to a lack of effective treatments, malignant peritoneal mesothelioma is often fatal and patients who are afflicted by it will live on .

Peritoneal mesothelioma is a relatively rare form of malignant mesothelioma, making up slightly less than 30% of diagnosed mesothelioma cases.

Malignant peritoneal mesothelioma (MPM) is a rare aggressive tumor of the In experienced hands, the diagnosis of malignant peritoneal mesothelioma can

Mesothelioma is a rare type of cancer that causes malignant cell development in Peritoneal mesothelioma patients may experience symptoms that include:

Pemetrexed Shows Promise in Treating Peritoneal Mesothelioma: Presented at ECCO "tri-modal" approach to treating malignant pleural mesothelioma.

To date, there is no standard treatment for unresectable malignant peritoneal mesothelioma; either best supportive care or systemic chemotherapy with .

Peritoneal mesothelioma sufferers may experience pain in the stomach, weight loss, Malignant mesothelioma (that is, the cancerous type of mesothelioma,

Common locations where malignant mesothelioma occurs in asbestos–exposed workers are the pleural and peritoneal regions. Pleural mesothelioma is cancer of .

Title: ALIMTA plus Gemcitabine as Front-Line Chemotherapy for Patients with Malignant Pleural or Peritoneal Mesothelioma. A Phase II Clinical Trial

Churg A: Malignant peritoneal mesothelioma. after remote abdominal radiation. Cancer. 1988;61:2019–2021. 14 Bilbey JH, Muller NL, Miller RR, Nelems

Malignant peritoneal mesothelioma Abdominal cavity showing the location of the peritoneum; peritoneal mesothelioma. is an extremely rare condition. .

Purpose: Malignant mesothelioma (MM) arising in the peritoneal cavity is a rare neoplasm characterized by peritoneal progression and for which there are

Pleural Mesothelioma Malignant mesothelioma, also known as mesothelioma cancer ... pericardial mesothelioma and peritoneal mesothelioma are less frequent.

Mesothelioma of the peritoneum is a rare malignant neoplasm easily mistaken by both surgeon and pathologist for one of the more common neoplasms of the

The processes leading to the development of peritoneal mesothelioma remain Incidence of malignant mesothelioma currently ranges from about 7 to 40 per

by Pablo R. Ros, Koenraad J. Mortele - 2007 - Medical - 500 pages
Diagnosis: Malignant peritoneal mesothelioma. Discussion: Malignant peritoneal mesothelioma represents less than one third of all mesotheliomas;

Background: Diffuse malignant peritoneal mesothelioma (DMPM) is a subset of peritoneal mesothelioma with a poor clinical outcome. We performed a prognostic

A laparotomy was performed that revealed peritoneal malignancy with ascites. A biopsy demonstrated that the tumor was malignant peritoneal mesothelioma.

Malignant Peritoneal mesothelioma (MPM) is a rare disease with a universally fatal outcome when managed in a traditional palliative manner.

A patient with malignant peritoneal mesothelioma and a diffuse pulmonary infiltrate is described. Computed tomographic scanning suggested lymphangitis

Malignant peritoneal mesothelioma in a 76-year-old woman with a history We report on a woman with malignant mesothelioma of the peritoneum. .

Keywords: Malignant peritoneal mesothelioma, Umbilical metastasis, Umbilical metastasis from malignant peritoneal mesothelioma is very uncommon. .

by Ann M. Dvorak, Rita A. Monahan-Earley - 1995 - Medical - 406 pages
Ingram, I... and Mann, JR Malignant peritoneal mesothelioma in childhood.and Moossa, AR Peritoneal malignant mesothelioma in a patient with ...
books.google.com/books?isbn=0849344905...

Another type of Mesothelioma Cancer is Peritoneal Mesothelioma. .The malignant Mesothelioma cancers might also metastasize, or spread, to other parts of

Owing the rarity of the malignant peritoneal mesothelioma (MPM) the clinical characteristics of the disease are not fully known; indeed MPM appears as a

by Victor L. Roggli, Tim D. Oury, Thomas A. Sporn - 2004 - Medical - 424 pages
Chilcote RR, Okagaki T: Diffuse malignant peritoneal mesothelioma in a 13-year-old girl: Report of a case and review of the literature.

Mesothelioma lawyer explains malignant mesothelioma types: pleural, peritoneal, and pericardial mesothelioma.

Winslow, D. J. and Taylor, H. B.: Malignant peritoneal mesothelioma-A clinicopathological analysis of 12 fatal cases. Cancer, 13: 127-136, 1960.

by Maurie Markman, Jerome L. Belinson - 1997 - Medical - 528 pages
Cisplatin-based intraperitoneal chemotherapy appears to be the best available treatment for malignant peritoneal mesothelioma at present (2). References 1.

The California malignant mesothelioma cancer lawyers at Paul & Hanley represent ... In the abdomen, it is called peritoneal mesothelioma; in the lungs,

Patients with peritoneal mesothelioma -- the kind that affects the abdomen ... There are four stages of malignant mesothelioma, which measure how far the

Key Phrases - SIPs: malignant mesothelioma cell lines, peritoneal cancer index, normal human mesothelial cells, mesothelial cell lines, mesothelioma cells

Mesothelioma - Types - Peritoneal Mesothelioma. Malignant mesothelioma is a relatively rare type of cancer that only develops in people who have experienced

Markman M, Kelsen D, Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma. Journal of Cancer Research .

... of mesothelioma that exists, and in its malignant form is the direct result of ... Learn more facts about Peritoneal mesothelioma by doing a search fo

Peritoneal Mesothelioma resources from around the web, ... Malignant mesothelioma is a disease in which cancerous cells in the mesothelium grow to an

Malignant pleural mesothelioma symptoms include shortness of breath, ... Also known as abdominal mesothelioma, peritoneal mesothelioma accounts for 10 to .

Malignant mesothelioma accounts for about 75% of all pleural ... Peritoneal mesothelioma is the second-most common form of asbestos-related cancer.

[

with malignant peritoneal mesothelioma associated with familial. Mediterranean fever. The patients had not been exposed to asbes-

Peritoneal mesothelioma symptoms and diagnosis. Malignant peritoneal ... PERITONEAL ... of cases, peritoneal mesothelioma is found incidentally

Title: ALIMTA (pemetrexed) Plus Gemcitabine (Gemzar) for Patients with Malignant Pleural or Peritoneal Mesothelioma who have not had previous chemotherapy

Malignant Peritoneal Mesothelioma, an article on Mesothelioma Lawsuit Articles - Read all about Malignant Peritoneal Mesothelioma and other subjects on .

Analysis of Factors Associated With Outcome in Patients With Malignant Peritoneal Mesothelioma Undergoing Surgical Debulking and Intraperitoneal .

Malignant Peritoneal Mesothelioma is neoplasm arising from the serosal lining of ... In many cases, malignant peritoneal mesothelioma is not diagnosed until

Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 1999; 70:6-12.

Primary Malignant Peritoneal Mesothelioma: A Report of Two Cases In Antman's study [22], patients with malignant peritoneal mesothelioma have had a

Peritoneal mesothelioma: about 20% of all mesothelioma cases are peritoneal mesothelioma-- tumor of peritoneum mesothelial cells that line the abdominal

Peritoneal mesothelioma involves the lining of the abdominal and pelvic cavities of malignant mesothelioma are directly linked to working with asbestos.

Peritoneal mesothelioma is a cancer of the peritoneum and therefore presents itself in the form of .Malignant Mesothelioma · Peritoneal Mesothelioma

According to the US National Cancer Institute, "Malignant mesothelioma is a disease in which .The diagnosis for Peritoneal Mesothelioma begins with .

Malignant Mesothelioma Research

2007-09-07T08:08:00.000-07:00

By Elizabeth Morgan
Malignant mesotheliomas are highly aggressive cancers, usually linked to asbestos exposure. Most patients survive approximately one year after diagnosis, and only seven percent of patients make it past five years. If not diagnosed early, these cancers are extremely difficult to treat. However, early diagnosis is a challenge because patients may be unaware of previous asbestos exposure or present with non-specific symptoms.

Research is currently underway to better understand how these cancers develop, and how to improve survival. The American Cancer Society and National Cancer Institute are good resources for information on ongoing clinical trials and enrollment criteria. Treatment options being researched can broadly be classified into radiotherapy, light or photodynamic therapy, drug or chemotherapy, biotherapy and immunotherapy. While radiotherapy is palliative in chest pain and chest wall spread, it has no effect on survival. Photodynamic therapy is being evaluated for earlier stages of malignant pleural mesothelioma; it combines the injection of a drug that makes cancer cells sensitive to light with the use of light of a certain wavelength to kill these cells.

A promising clinical trial showed patients with advanced malignant mesothelioma lived for nearly three months longer than a comparison group when treated with a drug combination of Alimtaä and cisplatin. The University of Chicago’s Cancer Research Center is leading a trial that combines the anti-cancer drugs gemcitabine and cisplatin, which kill cancer cells, with the biological agent bevacizumab, which slows the growth of cancerous tissue and blood vessels in this tissue. Researchers at the National Cancer Institute have identified a protein called mesothelin that is present in higher levels in mesothelioma cancer cells than in surrounding normal tissue. This knowledge is being used in ongoing clinical trials of vaccines that could kill cancer cells by triggering an anti-mesothelin immune response, and is also being used to develop diagnostic tests to detect rising mesothelin levels in people with malignant mesothelioma.

Malignant Mesothelioma provides detailed information about malignant mesothelioma, diffuse malignant pleural mesothelioma, malignant mesothelioma diagnosis, malignant mesothelioma lawyer and more. Malignant Mesothelioma is the sister site of Peritoneal Mesothelioma Lawyers.

Article Source: http://EzineArticles.com/?expert=Elizabeth_Morgan

Mesothelioma Prognosis: A Difficult Challenge to Face

2007-08-17T07:00:00.000-07:00

By Jeff Foster

Mesothelioma prognosis and mesothelioma treatment options depend on the size of the tumor, the stage of cancer, potential surgical removal of any tumor, amount of fluid in the chest or abdomen, overall health and age of patient, specific type of mesothelioma cancer cell and whether cancerous cells are found anywhere else in the body.

The mesothelioma prognosis is determined through physical examination and the results of a number of medical tests designed to evaluate the rare asbestos cancer. Once a mesothelioma prognosis is finally determined, then treating this aggressive and rare cancer can begin. Early diagnosis and treatment are most important in looking for a favorable mesothelioma prognosis.

Since mesothelioma is usually diagnosed at an advanced stage, the statistics for one to five year survival are usually unreliable.

The two most common types of mesothelioma are peritoneal (abdominal) mesothelioma and pleural (lung) mesothelioma, with pleural mesothelioma being the most common. Peritoneal mesothelioma can be difficult to stage because of its rarity. The initial symptoms of pleural mesothelioma are subtle and often ignored resulting in the cancer being more advanced when it is finally diagnosed causing it to be difficult to stage. However, because it is the most common of the mesothelioma cancers, pleural mesothelioma has multiple staging systems.

Unfortunately, patients who have been diagnosed with peritoneal or pleural mesothelioma are often advised of a grim mesothelioma prognosis, one which can often be less than one year survival expectancy from the time of diagnosis. Of course every patient is so different requires a different mesothelioma treatment plan and as a result of the individuality of each patient, an accurate mesothelioma prognosis must be individualized by your physician.

The mesothelioma prognosis has several important factors such as the patient’s overall health at the time of diagnosis, exact type of mesothelioma tumor, size of the mesothelioma tumor and precise location of the mesothelioma tumor. Normally mesothelioma is located near the vital organs such as the heart and lungs which can cause severe consequences if the cancerous tumors begin to press on these vital organs. It is important to remember that the healthier a patient is going in to treatment for malignant mesothelioma then the patient generally responds better to treatment and has a greater chance of a prolonged survival.

After properly being diagnosed with mesothelioma and a mesothelioma prognosis is made, the doctor and patient will discuss treatment options. Because there is currently no known cure for mesothelioma, treatment options are designed to relieve symptoms, try to prevent metastasis and to prolong life while maintaining an acceptable quality of life.

For more important information on mesothelioma be sure to visit a-mesothelioma-guide.com where you will find key information such as the symptoms of mesothelioma, risks, and other articles that you can view at http://www.a-mesothelioma-guide.com

Article Source: http://EzineArticles.com/?expert=Jeff_Foster

Peritoneal Mesothelioma Treatment Costs

2007-07-07T06:51:00.000-07:00

By Jason Gluckman
Peritoneal Mesothelioma is a form of cancer that attacks the lining of the abdomen, enveloping many of the organs in the abdomen by a thin membrane of mesothelial cells, known as the peritoneum. It is caused due to exposure to asbestos. This tumor as a long lactation period and is often diagnosed 30-50 years after the exposure. Though currently no treatment is available for curing this disease, a timely diagnosis (depending upon the size of the tumor), may in improve the patients’ quality of life. In some cases of early diagnosis, the treatments can result in extending the life of victim up to five years, in comparison to the normal lifespan of one year for a peritoneal mesothelioma patient. While the current survival rate for peritoneal mesothelioma patients is low, new peritoneal mesothelioma treatments are in development, and some show great promise. Radiation therapy, chemotherapy, and/or surgery are the most common options available today for the treatment of peritoneal mesothelioma.

The cost incurred in overall treatment of this tumor is almost the same as the cost involved in the treatment of other tumors. It is difficult to determine exact figures as there is variability in treatment plans, but cancer treatments can cost many thousands of dollars per month. Overall, cancer treatment, including peritoneal mesothelioma treatment, costs over $40 billion in the US each year. For a typical individual, who already has been victimized by this dreadful disease, the treatment costs can prove to very expensive and unaffordable. If you have been diagnosed and are suffering from peritoneal mesothelioma, it is advisable to consult a peritoneal mesothelioma lawyer, who can guide you as to your legal rights and how you can recover compensation from the party responsible for your exposure to asbestos. An expert lawyer can help you recover compensation for bills, lost wages, and punitive damages, which can go up to millions of dollars.

Mesotherapy provides detailed information about mesotherapy, cost of mesotherapy, mesotherapy before and after, mesotherapy injections and more. Mesotherapy is the sister site of Mesothelioma Doctors Info.

Article Source: http://EzineArticles.com/?expert=Jason_Gluckman

What is Peritoneal Mesothelioma?

2007-06-27T06:48:00.000-07:00

By Michael Kralj

Peritoneal Mesothelioma is a tumor of the membrane Peritoneum. The peritoneum is a thin membrane in the organs in the abdomen consisting of mesothelial cells.

Peritoneal Mesothelioma is associated to coming about from having previous exposure to asbestos, and in many cases is found through routine abdominal xrays and CT scans showing something different than normal.

Peritoneal Mesothelioma can stay dormant in your body for many years, before it will be seen, and for this reason many people years after they have been exposed to asbestos will be diagnosed with Peritoneal Mesothelioma. About 20% of all mesotheliomas are Peritoneal Mesothelioma, and they can be of two types: malignant and benign.

What are the Symptons of Peritoneal Mesothelioma?

- abdominal pains
- weakness
- weight loss
- loss of appetite
- nausea
- abdominal swelling

The symptoms become more severe over time and should be checked out by a doctor. If they do not, they will cause increasing pressure on your abdomen organs, causing much discomfort, and will lead to bowel obstruction and distention.

How is peritoneal mesothelioma diagnosed? A peritoneoscopy is performed, and if there is a reason to be concerned, a biopsy is performed. A biopsy is the process of taking a piece of tissue to be given to a pathologist for analysis. The pathologist uses a microscope to analyse the tissue and make the actual diagnosis.

Currently, it is still unknown why Asbestos causes the mesothelial cells to be cancerous, and it is unsure how many fibers are needed for the tumor to occur. Many treatments exist for peritoneal mesothelioma, however a cure has yet to be found.

What are some of the treatments available for Peritoneal Mesothelioma?
- chemotherapy
- radiation therapy
- surgery.

If you are feeling any of the symptoms noted above, ensure you have it checked out early. The earlier the diagnosis of Peritoneal Mesothelioma, the better chance the treatments will be effective.

Michael Kralj is author of the Blog Mesothelioma Info and Updates found at http://mesotheliomainfoupdates.blogspot.com. Learn more about Mesothelioma and its treatments.

Article Source: http://EzineArticles.com/?expert=Michael_Kralj

Malignant Peritoneal Mesothelioma

2007-05-07T06:36:00.000-07:00

By Jason Gluckman

Malignant Peritoneal Mesothelioma is neoplasm arising from the serosal lining of the peritoneal and pericardial cavities. Primary tumors arising from the Peritoneal Mesothelioma are extremely rare. The accurate diagnosis of the diffuse Peritoneal Mesothelioma is important because it almost invariably has a fatal outcome. In many cases, malignant Peritoneal Mesothelioma is not diagnosed until after surgery or autopsy. The distinction of the malignant Peritoneal Mesothelioma from tumors metastatic to the serosal membranes can often be made based on the results of histochemical studies.

The most common symptoms of malignant Peritoneal Mesothelioma are difficulty in breathing, chest pain, or both. Other symptoms include weight loss, fever, night sweats, cough, and a general feeling of not being well, although these symptoms are not as common.

The standard treatment for the malignant Peritoneal Mesothelioma is not curative. Aggressive treatment will enable some patients to experience long-term survival, but it is still unclear whether overall survival rates would be significantly changed by different treatments or combinations of treatments. There are different treatments available for the malignant Peritoneal Mesothelioma, depending upon the state of its diagnosis. For stage one, that is localized malignant Peritoneal Mesothelioma, standard treatments are malignant peritoneal mesothelioma, intracavitary mesothelioma, intracavitary chemotherapy following resection.

For stages 2 to 4, that is advanced malignant Peritoneal Mesothelioma, treatments available are symptomatic treatment to include drainage of effusions, chest tube pleurodesis, or thoracoscopic pleurodesis, palliative surgical resection in selected patients, palliative radiation therapy, single-agent chemotherapy, and multimodality clinical trials.

To date, there are no treatment approaches that have been shown to improve survival or control symptoms for a prolonged period of time. But with the advancement in the field of technology and medicine, there is hope that some day, doctors will be able to defeat the tumor and come out with some life-saving treatment against this dreadful tumor.

Mesotherapy provides detailed information about mesotherapy, cost of mesotherapy, mesotherapy before and after, mesotherapy injections and more. Mesotherapy is the sister site of Mesothelioma Doctors Info.

Article Source: http://EzineArticles.com/?expert=Jason_Gluckman

Peritoneal Mesothelioma Litigation

2007-04-27T06:32:00.000-07:00

By Jason Gluckman

Peritoneal Mesothelioma Litigation is the legal process wherein the victim of this dreadful disease seeks compensation for the physical and emotional damages it causes. Peritoneal mesothelioma is the cancer of the lining of the organs that develops as a result of toxic levels of exposure to asbestos in the air. The average survival time is one year, but if caught early, there is a one in two chance of surviving two years and a one in five chance of surviving five years. Peritoneal mesothelioma litigation allows a victim of this dreadful disease to seek compensation from their employer (if they were exposed to asbestos on the job) or from the manufacturer of asbestos-containing products. Through peritoneal mesothelioma litigation, a peritoneal mesothelioma victim may be able to recover damages associated with medical expenses, loss of income, and pain and suffering.

If you have been exposed to asbestos in the work place in the last 50 years, you may be at risk for developing mesothelioma. Medical professionals are able to measure the amount of asbestos fibers that are present in your body. If you have developed peritoneal mesothelioma as a result of this exposure, you may wish to contact a qualified attorney about peritoneal mesothelioma litigation. Peritoneal mesothelioma litigation attorneys can help maximize and protect your interests in a case. An experienced peritoneal mesothelioma lawyer can help you seek millions as compensation from your employer or from the asbestos manufacturing companies, who even being aware of the fact that asbestos exposure was hazardous, suppressed that medical knowledge and made billions of dollars in profits from the sale of asbestos-containing products.

Article Source: http://EzineArticles.com/?expert=Jason_Gluckman

Privacy Policy for Malignant peritoneal mesothelioma

2007-04-01T05:31:00.000-07:00

If you require any more information or have any questions about our privacy policy, please feel free to contact us by email at kedarah@hotmail.com.

At Malignant peritoneal mesothelioma, the privacy of our visitors is of extreme importance to us. This privacy policy document outlines the types of personal information is received and collected by Malignant peritoneal mesothelioma and how it is used.

Log Files
Like many other Web sites, Malignant peritoneal mesothelioma makes use of log files. The information inside the log files includes internet protocol ( IP ) addresses, type of browser, Internet Service Provider ( ISP ), date/time stamp, referring/exit pages, and number of clicks to analyze trends, administer the site, track user’s movement around the site, and gather demographic information. IP addresses, and other such information are not linked to any information that is personally identifiable.

Cookies and Web Beacons
Malignant peritoneal mesothelioma does use cookies to store information about visitors preferences, record user-specific information on which pages the user access or visit, customize Web page content based on visitors browser type or other information that the visitor sends via their browser.

Some of our advertising partners may use cookies and web beacons on our site. Our advertising partners include Google Adsense, Clickbank, .

These third-party ad servers or ad networks use technology to the advertisements and links that appear on Malignant peritoneal mesothelioma send directly to your browsers. They automatically receive your IP address when this occurs. Other technologies ( such as cookies, JavaScript, or Web Beacons ) may also be used by the third-party ad networks to measure the effectiveness of their advertisements and / or to personalize the advertising content that you see.

Malignant peritoneal mesothelioma has no access to or control over these cookies that are used by third-party advertisers.

You should consult the respective privacy policies of these third-party ad servers for more detailed information on their practices as well as for instructions about how to opt-out of certain practices. Malignant peritoneal mesothelioma's privacy policy does not apply to, and we cannot control the activities of, such other advertisers or web sites.

If you wish to disable cookies, you may do so through your individual browser options. More detailed information about cookie management with specific web browsers can be found at the browsers' respective websites.